Overview

Comparison of Three Methods of Hemoglobin Monitoring

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
0
Participant gender:
All
Summary
This study will further investigate the Masimo SpHb [FDA Approved] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- Male or non-pregnant female 18 y/o or older

- ASA Classification 1, 2 or 3

- Scheduled to undergo spine or hip revision surgery

Exclusion Criteria:

- Pregnant or nursing

- Patients who in the study investigators clinical judgement would not be suitable for
research.